Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies
- 30 June 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 45 (1-2), 1-14
- https://doi.org/10.1016/0165-5728(93)90157-t
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Isolation and Characterization of Cells Infiltrating the Spinal Cord during the Course of Chronic Relapsing Experimental Allergic Encephalomyelitis in the Biozzi AB/H MouseCellular Immunology, 1993
- Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH3International Journal of Immunopharmacology, 1991
- Suppression of demyelination by mitoxantroneInternational Journal of Immunopharmacology, 1991
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990
- Induction of tolerance in peripheral T cells with monoclonal antibodiesEuropean Journal of Immunology, 1990
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.The Journal of Experimental Medicine, 1987
- Tolerance to rat monoclonal antibodies. Implications for serotherapy.The Journal of Experimental Medicine, 1986
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984